Zometa (zoledronic acid) Novartis
HomeZometa International Site: For Non US healthcare professionals onlyUS ResidentsCountry Sites


About ZOMETA

Key Clinical Trial and Recent Publications | Zometa

ZOMETA for Your Practice

For Your Patients

Professional Resource Center

ZOMETA Around the World
Videos
View videos on bone
metastases and the Zometa
mechanism of action

Learn more about the Zometa (Zoledronic Acid) mechanism of action

 
European Summary of Product Characteristics
For non-U.S. Healthcare Professionals: Get information about Zometa and its product characteristics

Learn more about ZOMETA product characteristics 		 
Zometa®
Around the World
Country Sites
 
Austria
Austria		 Brazil
Brazil		 Canada
Canada
(English / Français)		 China
China
Germany
Germany		 Japan
Japan		 Netherlands
Netherlands		 Norway
Norway
Poland
Poland		 Sweden
Sweden		 Switzerland
Switzerland		 United States
United States
 

Disclaimer: This is an international website for ZOMETA® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

About ZOMETA | ZOMETA Clinical News | ZOMETA for Your Practice
ZOMETA for Your Patients | Professional Resource Center | ZOMETA Around the World

About Novartis OncologySiteMapContactPrivacy
 


Use of this website is subject to our Terms of Use
© 2008 Novartis Pharma AG.